AR092713A1 - Composiciones y metodos de uso de un compuesto para el control de la inapetencia - Google Patents
Composiciones y metodos de uso de un compuesto para el control de la inapetenciaInfo
- Publication number
- AR092713A1 AR092713A1 ARP130103486A ARP130103486A AR092713A1 AR 092713 A1 AR092713 A1 AR 092713A1 AR P130103486 A ARP130103486 A AR P130103486A AR P130103486 A ARP130103486 A AR P130103486A AR 092713 A1 AR092713 A1 AR 092713A1
- Authority
- AR
- Argentina
- Prior art keywords
- composition
- capromorelin
- livestock
- syringe
- administration
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 4
- 150000001875 compounds Chemical class 0.000 title 1
- KVLLHLWBPNCVNR-SKCUWOTOSA-N capromorelin Chemical compound C([C@@]12CN(CCC1=NN(C2=O)C)C(=O)[C@@H](COCC=1C=CC=CC=1)NC(=O)C(C)(C)N)C1=CC=CC=C1 KVLLHLWBPNCVNR-SKCUWOTOSA-N 0.000 abstract 4
- 229950004826 capromorelin Drugs 0.000 abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 abstract 4
- 239000000796 flavoring agent Substances 0.000 abstract 3
- 244000144972 livestock Species 0.000 abstract 3
- 241001465754 Metazoa Species 0.000 abstract 2
- 235000019634 flavors Nutrition 0.000 abstract 2
- 230000004596 appetite loss Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 235000013355 food flavoring agent Nutrition 0.000 abstract 1
- 238000007918 intramuscular administration Methods 0.000 abstract 1
- 235000021266 loss of appetite Nutrition 0.000 abstract 1
- 208000019017 loss of appetite Diseases 0.000 abstract 1
- 230000000873 masking effect Effects 0.000 abstract 1
- 238000007920 subcutaneous administration Methods 0.000 abstract 1
- 230000004580 weight loss Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/111—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/132—Heterocyclic compounds containing only one nitrogen as hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Dermatology (AREA)
- Feed For Specific Animals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Método para tratar la pérdida de peso inducida por inapetencia en uno o más animales de compañía o ganado. El método consiste en administrar una cantidad terapéuticamente efectiva en una composición con contenido de capromorelina al animal de compañía o ganado. Opcionalmente, se puede agregar uno o más agentes saborizantes o agentes enmascaradores del sabor a la composición con contenido de capromorelina para realzar o enmascarar el sabor de la composición para el animal de compañía o ganado. Reivindicación 22: El método de acuerdo con la reivindicación 1, en el cual la administración de la composición con contenido de capromorelina es seleccionada del grupo que consiste en administración oral, administración intramuscular y administración subcutánea. Reivindicación 111: Un kit para usar en el tratamiento de la inapetencia en animales no humanos, kit que comprende: una jeringa; un recipiente que contiene una formulación farmacéutica, formulación farmacéutica que comprende una composición con contenido de capromorelina e indicaciones para instruir a un usuario para retirar aproximadamente una dosis de la formulación farmacéutica del recipiente empleando la jeringa y administrar la composición farmacéutica al animal no humano utilizando la jeringa.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261706164P | 2012-09-27 | 2012-09-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR092713A1 true AR092713A1 (es) | 2015-04-29 |
Family
ID=50339468
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP130103486A AR092713A1 (es) | 2012-09-27 | 2013-09-27 | Composiciones y metodos de uso de un compuesto para el control de la inapetencia |
| ARP210102942A AR123902A2 (es) | 2012-09-27 | 2021-10-22 | Composición veterinaria oral para el control de inapetencia para un gato o un perro |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP210102942A AR123902A2 (es) | 2012-09-27 | 2021-10-22 | Composición veterinaria oral para el control de inapetencia para un gato o un perro |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US11090292B2 (es) |
| EP (3) | EP4302825A3 (es) |
| JP (2) | JP6779618B2 (es) |
| KR (5) | KR20230097201A (es) |
| CN (2) | CN105072909A (es) |
| AR (2) | AR092713A1 (es) |
| AU (2) | AU2013323349B2 (es) |
| BR (1) | BR112015006282B1 (es) |
| CA (1) | CA2886091C (es) |
| DK (1) | DK3524260T3 (es) |
| ES (1) | ES2959427T3 (es) |
| MX (2) | MX2015003564A (es) |
| NZ (2) | NZ707174A (es) |
| PL (1) | PL3524260T3 (es) |
| PT (1) | PT3524260T (es) |
| RU (1) | RU2648958C2 (es) |
| TW (3) | TW202106298A (es) |
| WO (1) | WO2014052780A2 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011105611A1 (ja) | 2010-02-26 | 2011-09-01 | ラクオリア創薬株式会社 | 悪液質を治療するためのグレリン受容体作動物質 |
| US10039813B2 (en) | 2012-02-07 | 2018-08-07 | Massachusetts Institute Of Technology | Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness |
| DK3524260T3 (da) | 2012-09-27 | 2023-10-09 | Elanco Animal Health Incorporated | Farmaceutiske sammensætninger til behandling af manglende appetit |
| WO2014144231A1 (en) | 2013-03-15 | 2014-09-18 | Massachusetts Institute Of Technology | Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness |
| JP6467513B2 (ja) * | 2015-01-28 | 2019-02-13 | アラタナ セラピューティクス、 インコーポレイテッド | 体重増加用化合物の長期使用のための組成物と方法 |
| WO2016138099A1 (en) | 2015-02-24 | 2016-09-01 | Massachusetts Institute Of Technology | Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness |
| WO2018089723A1 (en) * | 2016-11-11 | 2018-05-17 | Hill's Pet Nutrition, Inc. | Compositions and methods of pet food |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US193273A (en) * | 1877-07-17 | Improvement in material for pulley-covers | ||
| JP2893901B2 (ja) * | 1990-09-07 | 1999-05-24 | 株式会社岐阜免疫研究所 | 動物用抗体含有油性ペースト製剤 |
| CA2095786A1 (en) | 1992-05-08 | 1993-11-09 | Franco J. Vaccarino | Method of stimulating appetite |
| TW432073B (en) | 1995-12-28 | 2001-05-01 | Pfizer | Pyrazolopyridine compounds |
| EP1159964B1 (en) | 2000-05-31 | 2009-10-28 | Pfizer Products Inc. | Use of growth hormone secretagogues for stimulating gastrointestinal motility |
| EP1181933A3 (en) * | 2000-06-29 | 2002-04-10 | Pfizer Products Inc. | Use of growth hormone secretagogues for stimulating or increasing appetite |
| US8309603B2 (en) * | 2004-06-07 | 2012-11-13 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
| US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
| US7491695B2 (en) * | 2003-06-18 | 2009-02-17 | Tranzyme Pharma Inc. | Methods of using macrocyclic modulators of the ghrelin receptor |
| WO2005097173A2 (en) * | 2004-04-07 | 2005-10-20 | Gastrotech Pharma A/S | Use of ghrelin for the treatment of hyperthyroidism |
| EP1812045A2 (en) * | 2004-10-27 | 2007-08-01 | Gastrotech Pharma A/S | Uses of secretagogues for treatment of organ transplant patients |
| JP2009514824A (ja) * | 2005-11-02 | 2009-04-09 | ネステク ソシエテ アノニム | 雄の哺乳動物における体脂肪の蓄積を低減するためのイソフラボン組成物及びその使用方法 |
| AU2007227641B2 (en) * | 2006-03-13 | 2012-11-29 | Liat Mintz | Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite stimulation |
| AU2007300526B2 (en) | 2006-09-27 | 2011-07-21 | Ipsen Pharma S.A.S. | Analogs of ghrelin substituted at the N-terminal |
| JP2008127377A (ja) * | 2006-11-24 | 2008-06-05 | Jichi Medical Univ | Ｇｈｓ−ｒ作動薬を含有してなるメタボリックシンドローム又は高血圧症の予防・治療剤。 |
| US20080226802A1 (en) * | 2007-03-14 | 2008-09-18 | Concentrate Manufacturing Company Of Ireland | Beverage having natural sweeteners with one or more stevia components and source of berry |
| TWI429436B (zh) | 2007-04-10 | 2014-03-11 | Helsinn Therapeutics Us Inc | 使用生長激素促泌素治療或預防嘔吐之方法 |
| RU2007129408A (ru) * | 2007-07-31 | 2009-02-10 | Игорь Николаевич Жирков (RU) | Способ выращивания поросят в период откорма |
| FR2920295B1 (fr) | 2007-09-05 | 2009-12-11 | Desvac | Dispositif d'injection de produits veterinaires a des volailles, comprenant un element de contention presentant une forme anatomique incluant des moyens de calage d'un os reperable |
| CN101854814B (zh) * | 2007-11-12 | 2013-07-31 | 三荣源有限公司 | 改善甜叶菊提取物甜味的方法 |
| EP2412713B1 (en) * | 2009-03-26 | 2016-11-30 | Takeda Pharmaceutical Company Limited | Pyrazole compound |
| WO2011105611A1 (ja) * | 2010-02-26 | 2011-09-01 | ラクオリア創薬株式会社 | 悪液質を治療するためのグレリン受容体作動物質 |
| DK3524260T3 (da) | 2012-09-27 | 2023-10-09 | Elanco Animal Health Incorporated | Farmaceutiske sammensætninger til behandling af manglende appetit |
-
2013
- 2013-09-27 DK DK19161662.2T patent/DK3524260T3/da active
- 2013-09-27 NZ NZ707174A patent/NZ707174A/en active IP Right Revival
- 2013-09-27 KR KR1020237019962A patent/KR20230097201A/ko not_active Application Discontinuation
- 2013-09-27 BR BR112015006282-2A patent/BR112015006282B1/pt active IP Right Grant
- 2013-09-27 AR ARP130103486A patent/AR092713A1/es not_active Application Discontinuation
- 2013-09-27 TW TW109121986A patent/TW202106298A/zh unknown
- 2013-09-27 CN CN201380061931.6A patent/CN105072909A/zh active Pending
- 2013-09-27 TW TW107142255A patent/TWI732158B/zh active
- 2013-09-27 ES ES19161662T patent/ES2959427T3/es active Active
- 2013-09-27 KR KR1020157009647A patent/KR20150058345A/ko not_active IP Right Cessation
- 2013-09-27 TW TW102135177A patent/TWI667024B/zh active
- 2013-09-27 CA CA2886091A patent/CA2886091C/en active Active
- 2013-09-27 KR KR1020197037811A patent/KR20190143484A/ko active Application Filing
- 2013-09-27 JP JP2015534747A patent/JP6779618B2/ja active Active
- 2013-09-27 PL PL19161662.2T patent/PL3524260T3/pl unknown
- 2013-09-27 NZ NZ746394A patent/NZ746394A/en unknown
- 2013-09-27 RU RU2015114996A patent/RU2648958C2/ru active
- 2013-09-27 EP EP23191187.6A patent/EP4302825A3/en active Pending
- 2013-09-27 KR KR1020217042990A patent/KR20220003640A/ko not_active IP Right Cessation
- 2013-09-27 EP EP19161662.2A patent/EP3524260B1/en active Active
- 2013-09-27 KR KR1020217001509A patent/KR20210009438A/ko not_active Application Discontinuation
- 2013-09-27 MX MX2015003564A patent/MX2015003564A/es active IP Right Grant
- 2013-09-27 AU AU2013323349A patent/AU2013323349B2/en active Active
- 2013-09-27 EP EP13841455.2A patent/EP2906041A4/en not_active Withdrawn
- 2013-09-27 PT PT191616622T patent/PT3524260T/pt unknown
- 2013-09-27 CN CN202010001164.1A patent/CN111419845A/zh active Pending
- 2013-09-27 WO PCT/US2013/062227 patent/WO2014052780A2/en active Application Filing
- 2013-09-27 US US14/039,114 patent/US11090292B2/en active Active
-
2015
- 2015-03-19 MX MX2022015141A patent/MX2022015141A/es unknown
-
2016
- 2016-08-22 AU AU2016216741A patent/AU2016216741B2/en active Active
-
2018
- 2018-03-07 JP JP2018041063A patent/JP6796097B2/ja active Active
-
2021
- 2021-10-22 AR ARP210102942A patent/AR123902A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR092713A1 (es) | Composiciones y metodos de uso de un compuesto para el control de la inapetencia | |
| EA201790568A1 (ru) | Применение двойного агониста рецепторов glp-1/глюкагона пролонгированного действия для лечения неалкогольной жировой болезни печени | |
| CR20110270A (es) | Piriloxi-indoles Inhibidores del VEGF-R2 y Uso de los Mismos para el Tratamiento de Enfermedades | |
| EA201100896A1 (ru) | Композиция, предназначенная для всасывания никотина из ротовой полости с целью прекратить курение | |
| BR112012023139A2 (pt) | composição farmacêutica para a prevenção ou o tratamento de doença do fígado gordo não alcóolico e o método para a prevenção ou tratamento de doença do fígado gordo não alcóolico usando a mesma. | |
| PE20160194A1 (es) | Composiciones y metodos para tratar anemia | |
| BRPI0911031B8 (pt) | compostos de piperidina ligada do tipo quinoxalina substituídos e os usos destes | |
| BR112013020802A2 (pt) | métodos e composições para tratar, reduzir ou impedir dano ao sistema nervoso de animais | |
| BR112016024020A8 (pt) | composição farmacêutica | |
| GB2523707A (en) | Novel pharmaceutical formulations and their use in the treatment of periodontal disease | |
| CO2019004004A2 (es) | Composición farmacéutica y método para el tratamiento de la enfermedad del hígado graso no alcohólico | |
| BR112012020377A8 (pt) | utilização de um ou mais selecionado do grupo constituído por um composto da fórmula (i), uma mistura racêmica-diastereomérica e um isômero óptico do referido composto, e um sal farmaceuticamente aceitável e uma pródroga do mesmo, método, composição farmacêutica e kit para tratamento de caquexia e embalagem comercial | |
| BR112013021497A2 (pt) | novo uso de composições para prevenir alopecia induzida por quimioterapia e radioterapia (cria), reduzir o impacto da cria e melhorar a aparência do cabelo recrescido depois da cria | |
| EA201391023A1 (ru) | Способ снижения боли у животных семейства собачьих с помощью трансдермального раствора фентанила | |
| TR201908936T4 (tr) | Opioidler ile kombinasyon halinde palmitoiletanolamid kullanımı. | |
| BR112013016554A2 (pt) | métodos e composições úteis para promover sono nos animais | |
| AR103555A1 (es) | Composiciones y métodos para el uso crónico de un compuesto para aumentar el peso | |
| ECSP19000167A (es) | Métodos y composiciones para el tratamiento de la hipercalciuria y la nefrolitiasis | |
| BR112017001589A2 (pt) | peptídeos marinhos e nucleotídeos de peixe, composições e usos dos mesmos para reduzir a glicose no sangue | |
| EA201590097A1 (ru) | Составы с однократной дозой для перорального введения и способы лечения кошек с помощью спиносада, уничтожающего эктопаразитов | |
| BR112018077032A2 (pt) | método para aprimorar o crescimento ou a conversão alimentar em um animal, uso de pgn, mdp ou um análogo de mdp na preparação de um medicamento e pgn, mdp ou um análogo de mdp | |
| DOP2013000004A (es) | Agentes terapeuticos 976 | |
| RU2011108858A (ru) | Средство для повышения роста и сохранности молодняка | |
| AR128434A2 (es) | Composiciones y métodos de absorción transmucosa | |
| MD408Y (en) | Method for prophylaxis and treatment of ectoparasitosis in hens |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |